about
Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenEarly-life exposures to infectious agents and later cancer developmentAssociation of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients.Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma.HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphomaEpstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China.Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritisAssessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.EBV in Hodgkin Lymphoma.The role of Epstein-Barr virus in cancer.Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.Epstein-Barr virus-associated lymphomas.Epstein-Barr virus in hepatocellular carcinogenesis.KIR Genes and Patterns Given by the A Priori Algorithm: Immunity for Haematological Malignancies.Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies.HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaLymphoreticular diseases in Nigerians.Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas.Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Primary pulmonary Hodgkin's lymphoma and a review of the literature since 2006Epstein-Barr virus: novel patented therapeutics.Targetable molecular pathways in classical Hodgkin's lymphoma.Multiple infections and cancer: implications in epidemiology.Adoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors.Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.Chest neoplasms with infectious etiologies.Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T CellsWhole blood EBV-DNA: A surrogate for immune dysfunction in aggressive lymphoma?Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins
P2860
Q24633907-22B77BA2-5EEE-485D-80F6-B00D9CB3F0BAQ26786103-AB5D0046-74AE-42F8-B38C-4F61520B8DBEQ33283515-466609C2-E8D9-4352-AEDB-DE5B677E61BEQ33416615-BAE8E5B9-35CB-4090-9AD4-1ED19C25E286Q33435995-472AADDE-95B2-4908-A811-50003B42F6ACQ33595804-D07675ED-F0AB-46A1-9ED7-ABB46E66FDF6Q33645331-93560415-7166-49BB-97A0-64CD7B945049Q33778708-415A6E30-6146-4944-9419-18F75465644EQ33918638-E8395CF9-A329-4FF5-8C90-8645B5B4CC5AQ33939509-69F6DF6D-15D0-4FFC-ADDC-5D96671E3AA0Q34352415-C035F2AB-F180-4A96-9440-5BF47843ACABQ34376405-ADAE9AE5-D580-47ED-BB3D-0302AA98AF82Q34548411-253244AA-3C60-450F-B365-18B8EC000F41Q34549468-E325C3E9-1A36-43ED-BACA-215E88C72286Q34574840-F018030C-23C9-44D0-9E38-0464F5AA002DQ34619694-9BC5BAB6-DBA3-4F13-A9F0-EAD6391CD502Q34651670-D0AA16FD-8D2F-4290-9EBD-0B88F89D73D1Q36076328-8B65CC53-E0BC-4262-B8DA-58EE931052B6Q36163789-9F29D856-29BC-4027-8621-66F734BEC3CFQ36303951-0F767959-029D-4AEC-9611-9F687DD515ACQ36320074-5408DCE7-A8BC-4D7E-8DF1-2E883B344048Q36457849-4EBC3A5D-F771-46AD-8B17-4D1B83B43884Q36691291-1E11780D-BBCB-47C6-9C28-7341F33AB916Q36839720-A93E5CE5-CC22-44CF-8887-C04714B6BD97Q37039112-5F5314E4-95B1-4B98-8672-CEBF2F396405Q37280924-E91F50F8-DF87-4C82-8B1B-1F6C4EF48817Q37405297-2AD5CB1C-52CE-4F2B-90E3-A7059886EB0AQ37532169-C235620E-5A6F-43D0-80AC-79C57C1DF283Q37704302-860CBD35-8CF3-4114-8A42-07454B10E779Q37729167-139028F6-6C11-4499-B29B-72C44609D619Q37825891-8268E1CF-CF31-43A0-883B-33B6B4BD81D8Q38126931-09CDB0B4-4639-4D42-8F6B-4784C518F359Q38525041-0DB24D17-CE7E-4A57-8FAA-2A7D4CF36FC1Q38854742-30B214B9-2C79-4091-AE06-BCA961FF12ACQ40134553-CBF9C447-A795-4794-B063-8F14D79E0EDFQ40176475-7D213C22-53F0-4D5B-A481-904585DB6F2CQ40538712-1AD840B9-5354-4E21-A65B-890467B9A736Q40625940-455D1CAC-3B4B-444A-8F58-D1A4F742A313Q41027997-A3FDFBFF-745E-4138-BEFB-A5FBD03C5577Q41253332-7B1EB691-F9E4-4ADD-B41B-3A0E12616081
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Epstein-Barr virus-associated Hodgkin's lymphoma.
@ast
Epstein-Barr virus-associated Hodgkin's lymphoma.
@en
Epstein-Barr virus-associated Hodgkin's lymphoma.
@nl
type
label
Epstein-Barr virus-associated Hodgkin's lymphoma.
@ast
Epstein-Barr virus-associated Hodgkin's lymphoma.
@en
Epstein-Barr virus-associated Hodgkin's lymphoma.
@nl
prefLabel
Epstein-Barr virus-associated Hodgkin's lymphoma.
@ast
Epstein-Barr virus-associated Hodgkin's lymphoma.
@en
Epstein-Barr virus-associated Hodgkin's lymphoma.
@nl
P2860
P1476
Epstein-Barr virus-associated Hodgkin's lymphoma
@en
P2093
Judy T Tellam
Maher K Gandhi
P2860
P304
P356
10.1111/J.1365-2141.2004.04902.X
P407
P50
P577
2004-05-01T00:00:00Z